Opinion Pieces Address Various Topics Related To COVID-19, Including R&D; Global Immunization Efforts, Access; Scientific Advancement; Lessons Learned

The Conversation: The top scientific breakthrough for 2020 was understanding SARS-CoV-2 and how it causes COVID-19 — and then developing multiple vaccines
David Pride, associate director of microbiology at the University of California San Diego (12/17).

The Guardian: Covid is a chance to build a world where everyone has access to basic vaccines
David Miliband, CEO of the International Rescue Committee, and Anuradha Gupta, deputy CEO of Gavi, the Vaccine Alliance (12/18).

The Lancet: Science during COVID-19: where do we go from here?
Editorial Board (12/19).

Nature: The WHO’s chief scientist on a year of loss and learning
Soumya Swaminathan, chief scientist at the World Health Organization (12/17).

STAT: Emergency use authorization of Covid-19 vaccines could hinder global access to them
Safura Abdool Karim, public health lawyer, researcher at the SAMRC Centre for Health Economics and Decision Science at the Wits School of Public Health in Johannesburg and 2020 Aspen New Voices fellow (12/18).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.